COVID-19 Updates from NAHC

Moderna Announces Full US Approval for its COVID-19 Vaccine

Moderna announced Monday that U.S. health regulators granted full approval to its COVID-19 vaccine, a shot that’s been given to tens of millions of Americans since its emergency authorization over a year ago.

The action by the Food and Drug Administration means the agency has completed the same rigorous, time-consuming review of Moderna’s shot as dozens of other long-established vaccines.

The decision was bolstered by real-world evidence from the more than 200 million doses administered in the U.S. since the FDA cleared the shot in December 2020. The FDA granted full approval of Pfizer’s vaccine last August.

Read more

'Stealth' Omicron Variant BA.2 Circulating in Almost Half of US, but CDC Exercises Caution: Report

Is BA.2 going to be omicron 2.0?

There are now at least 127 known cases of the subvariant BA.2, otherwise known as the "stealth" variant, circulating in almost half of the United States that international experts suggest is more contagious as omicron, according to a recent CNBC report.

But Kristen Nordlund, a CDC spokesperson, in a Monday statement to The Washington Post, cautions, "Currently, there are insufficient data to determine whether the BA.2 lineage is more transmissible or has a fitness advantage over the BA.1 lineage[omicron]."

Read more

What Causes Long Covid? Scientists are Zeroing in on the Answer.

Even as the number of new Covid-19 cases in the US is dropping, hundreds of thousands of Americans are still testing positive every day. More than 28 million new cases have been reported since Omicron emerged in the US just two months ago, and the variant now drives 99.9 percent of cases, as of January 22, according to the Centers for Disease Control and Prevention.

Thanks to vaccines, boosters, and increasingly available treatments, most people who get infected today won’t end up in the hospital or die. A big question, however, looms over the survivors: What about long Covid?

Read more